Patent · US Expired

Antigenic compositions and methods for using same

US4557931A · kind A · utility

22Cited by
0References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 2, 1982
Grant dateDec 10, 1985
Priority date
Expiry dateDec 2, 2002

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/961
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

GM2 is a ganglioside present on the surface of tumors and stimulates an appreciable immune response in mammals. It is useful when coupled with a non-toxic protein carrier or mixed with an adjuvent and injected parenterally of raising the anti-GM2 titer in serum. GM2 is also valuable as a diagnostic agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.